Abstract The growth hormone secretagogue receptor (GHSR1a), the target of the ghrelin peptide, is widely distributed throughout the brain, and, while studies have often reported very low or absent levels of central ghrelin, it is now known that GHSR1a, even in the absence of a natural ligand, has physiological roles
Having this biomarker contextalongside your clinical symptoms and provider assessmentempowers you to advocate for monitoring strategies, dosing adjustments, or alternative treatments that minimize interaction risk while treating infections effectively
The final weight loss number from Phase 3 could be higher than 24.2%, or the plateau could appear early in the extended timeline
But GLP-1s Carry Serious Risks for People With Type 1 Diabetes Despite the strong results, theres a reason why experts are very cautious about recommending the use of semaglutide and tirzepatide for people with type 1 diabetes